Atorvastatin therapy in COVID-19 adult inpatients: A double-blind, randomized controlled trial

INTRODUCTION: Efficacious therapies are urgently required to tackle the coronavirus disease 2019 (COVID-19). This trial aims to evaluate the effects of atorvastatin in comparison with standard care for adults hospitalized with COVID-19. METHODS: We conducted a randomized controlled clinical trial on...

Descripción completa

Detalles Bibliográficos
Autores principales: Davoodi, Lotfollah, Jafarpour, Hamed, Oladi, Ziaeddin, Zakariaei, Zakaria, Tabarestani, Mohammad, Ahmadi, Bahareh Moayed, Razavi, Alireza, Hessami, Amirhossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437805/
https://www.ncbi.nlm.nih.gov/pubmed/34541293
http://dx.doi.org/10.1016/j.ijcha.2021.100875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437805/
https://www.ncbi.nlm.nih.gov/pubmed/34541293
http://dx.doi.org/10.1016/j.ijcha.2021.100875

Ejemplares similares